Recombinant multi-species DHX34 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine DHX34 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
DEAD box proteins, characterized by the conserved motif Asp-Glu-Ala-Asp (DEAD), are putative RNA helicases. They are implicated in a number of cellular processes involving alteration of RNA secondary structure such as translation initiation, nuclear and mitochondrial splicing, and ribosome and spliceosome assembly. Based on their distribution patterns, some members of this DEAD box protein family are believed to be involved in embryogenesis, spermatogenesis, and cellular growth and division. This gene encodes a member of this family. It is mapped to the glioma 19q tumor suppressor region and is a tumor suppressor candidate gene. [provided by RefSeq, Jul 2008]
The Alternative Names of target: 1200013B07Rik,1810012L18Rik,DDX34,DEAH box protein 34,DExH-box helicase 34,DHX34,Ddx34,Dhx34,HRH1,Probable ATP-dependent RNA helicase DHX34,mKIAA0134

Target products collectionGo to DHX34 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP13876-Ag-1/ GM-Tg-hg-IP13876-Ag-2 Human DHX34 protein Human
GM-Tg-rg-IP13876-Ag-1/ GM-Tg-rg-IP13876-Ag-2 Rat DHX34 protein Rat
GM-Tg-mg-IP13876-Ag-1/ GM-Tg-mg-IP13876-Ag-2 Mouse DHX34 protein Mouse
GM-Tg-cynog-IP13876-Ag-1/ GM-Tg-cynog-IP13876-Ag-2 Cynomolgus/Rhesus macaque DHX34 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP13876-Ag-1/ GM-Tg-felg-IP13876-Ag-2 Feline DHX34 protein Feline
GM-Tg-cang-IP13876-Ag-1/ GM-Tg-cang-IP13876-Ag-2 Canine DHX34 protein Canine
GM-Tg-bovg-IP13876-Ag-1/ GM-Tg-bovg-IP13876-Ag-2 Bovine DHX34 protein Bovine
GM-Tg-equg-IP13876-Ag-1/ GM-Tg-equg-IP13876-Ag-2 Equine DHX34 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP13876-Ag-1/ GM-Tg-hg-IP13876-Ag-2; GM-Tg-rg-IP13876-Ag-1/ GM-Tg-rg-IP13876-Ag-2;
GM-Tg-mg-IP13876-Ag-1/ GM-Tg-mg-IP13876-Ag-2; GM-Tg-cynog-IP13876-Ag-1/ GM-Tg-cynog-IP13876-Ag-2;
GM-Tg-felg-IP13876-Ag-1/ GM-Tg-felg-IP13876-Ag-2; GM-Tg-cang-IP13876-Ag-1/ GM-Tg-cang-IP13876-Ag-2;
GM-Tg-bovg-IP13876-Ag-1/ GM-Tg-bovg-IP13876-Ag-2; GM-Tg-equg-IP13876-Ag-1/ GM-Tg-equg-IP13876-Ag-2
Products Name DHX34 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name DHX34
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine DHX34 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.